Exploration of Metabolite Biomarkers to Predict the Efficacy of Dupilumab Treatment for Atopic Dermatitis

Figure 4

Change in EASI at 16 weeks from baseline between patient groups with predicted probabilities ≥0.855 and <0.855. The optimal predicted probability cut-off value of 0.855 was determined in Figure 3. The x-axis represents the patient groups with predicted probabilities ≥0.855 and <0.855; the y-axis represents the percent change in EASI at 16 weeks from baseline. The normality of the data distribution was verified using Shapiro–Wilk test. Statistical significances were analysed using Student’s t-test. Error bar is standard deviation; , , and .